Segment Information (Tables)

9 Months Ended

Sep. 30, 2015

Segment Reporting [Abstract]

Financial Performance of Reporting Segments

The following table summarizes the financial performance of our reportable segments, including a reconciliation of income from segment operations to income from total operations:

	Three Months Ended
	September 30, 2015						September 30, 2014
	Automation and Analytics		Medication Adherence		Total		Automation and Analytics		Medication Adherence		Total
	(In thousands)
Revenues	$	102,967	$	22,267	$	125,234	$	89,547	$	22,996	$	112,543
Cost of revenues	45,668		15,863		61,531		38,412		14,585		52,997
Gross profit	57,299		6,404		63,703		51,135		8,411		59,546
Operating expenses	30,628		6,070		36,698		27,420		4,822		32,242
Income from segment operations	$	26,671	$	334	$	27,005	$	23,715	$	3,589	$	27,304
Corporate costs					13,146						13,707
Income from operations					$	13,859					$	13,597

	Nine Months Ended
	September 30, 2015						September 30, 2014
	Automation and Analytics		Medication Adherence		Total		Automation and Analytics		Medication Adherence		Total
	(In thousands)
Revenues	$	284,447	$	69,796	$	354,243	$	255,748	$	63,611	$	319,359
Cost of revenues	123,923		47,470		171,393		109,344		39,934		149,278
Gross profit	160,524		22,326		182,850		146,404		23,677		170,081
Operating expenses	85,195		18,321		103,516		78,566		14,273		92,839
Income from segment operations	$	75,329	$	4,005	$	79,334	$	67,838	$	9,404	$	77,242
Corporate costs					42,672						41,133
Income from operations					$	36,662					$	36,109

_________________________________________________